pharmaceutical industry

The guidelines took years to finalize, but while regulators were drafting them, a new trend emerged: online pharmaceutical influencers with little government oversight.

Attorney General Ashley Moody wanted the Florida Supreme Court to resolve a legal battle about whether local agencies could pursue lawsuits after she reached settlements with the pharmaceutical industry.

The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.

About 350 million people suffer from rare diseases, most of which are genetic. But the individual disorders affect relatively few people, so there’s little commercial incentive to bring these treatments to market.

Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development nor their therapeutic value, research shows.

Supreme Court's decision to review the controversial bankruptcy deal involving the maker of Oxycontin means the settlement will remain on hold at least through December.

Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by President Donald Trump.

The Danish drugmaker's move follows a similar announcement by rival Eli Lilly earlier this month. More than 8 million Americans use insulin, according to the American Diabetes Association.

Hillsborough County Circuit Judge Ronald Ficarrotta was appointed to preside over the panel, which will convene for a year. Grand jury members will be drawn from five judicial circuits.

While supporters cheer the PASTEUR Act as an essential strategy to stem the rise of antibiotic-resistant pathogens, critics call it a multibillion-dollar giveaway to Big Pharma.